Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synvisc-One in Chinese Patients with Knee Osteoarthritis
NCT03190369Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2017
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by Sanofi. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index A1 Pain Subscale Score at 26 weeks. Started Aug 2017; status: completed.
Beyond the preview
Go deeper on NCT03190369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03190369.